GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

88.16 +2.29 (+2.67%)

Streaming Delayed Price Updated: 11:26 AM EDT, Sep 9, 2026 Add to My Watchlist

Price and Volume

Volume	170,561
Open	84.22
Bid (Size)	87.94 (300)
Ask (Size)	88.31 (100)
Prev. Close	85.87
Today's Range	84.00 - 88.16
52wk Range	32.21 - 170.87
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

Today 8:30 EDT

From GeneDx

Via Business Wire

GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree

September 01, 2026

From GeneDx

Via Business Wire

Performance

YTD	-33.4%	-33.4%
1 Month	+13.2%	+13.2%
3 Month	+56.5%	+56.5%
6 Month	-0.8%	-0.8%
1 Year	-31.8%	-31.8%

More News

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s

August 24, 2026

From GeneDx

Via Business Wire

GeneDx Holdings (NASDAQ:WGS) Beats Q2 Revenue Estimates and Swings to Adjusted Profit ↗

August 03, 2026

Via Chartmill

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

August 11, 2026

From GeneDx

Via Business Wire

GeneDx (WGS) Q2 2026 Earnings Call Transcript ↗

August 10, 2026

Via The Motley Fool

GeneDx to Participate in Upcoming Investor Conferences

August 06, 2026

From GeneDx

Via Business Wire

GeneDx Q2 Earnings Call Highlights ↗

August 03, 2026

Via MarketBeat

GeneDx Reports Second Quarter 2026 Financial Results

August 03, 2026

From GeneDx

Via Business Wire

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

August 03, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall Law

Via GlobeNewswire

GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 31, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Urges GeneDx Holdings Corp. Investors to Contact the Firm Regarding Lead Plaintiff Deadline

July 31, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 31, 2026

Via Newsfile

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 30, 2026

From SkyMedia, LLC

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 29, 2026

Via Newsfile

WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

July 29, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 28, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

July 28, 2026

From Pomerantz LLP

Via GlobeNewswire

GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm

July 27, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 27, 2026

Via Newsfile

GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

July 27, 2026

Via NewMediaWire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 24, 2026

Via Newsfile

WGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights

July 23, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 23, 2026

From SkyMedia, LLC

Via GlobeNewswire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?

Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.

What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?

GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?

The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market

What is the current price of GeneDx Holdings Corp. - Class A Common Stock?

The current price of GeneDx Holdings Corp. - Class A Common Stock is 88.16

When was GeneDx Holdings Corp. - Class A Common Stock last traded?

The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 09/09/26 11:26 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.